Electronic copies of our ImmNuz newsletter for Health Professionals
Home › News and Community › Newsletter ›
Newsletter
- World Immunisation Week 2013
- Pregnant women can have free Boostrix®
- Professional Development Days in Auckland and Wellington
- 2013 National Immunisation Workshop & Conference
- The End of Polio campaign
- Gardasil® eligibility
- Contraindications and precautions for immunisation
2013
- 2013 National Immunisation Workshop & Conference
- National Children’s Day & WellChild Tamariki Ora Week 2013
- Injection technique does matter
- Tdap immunisation and pregnancy
- Immunisation for breastfeeding women
- Timing of BCG and other immunisations
- Catching up infant immunisations
2012
- Announcing the 2013 National Immunisation Workshop & Conference
- Report on the National Immunisation Workshop 2012
- Newborn Pre-enrolment Toolkit
- National Guidelines for Vaccine Storage and Distribution 2012
- Annual Cold Chain Management Guide
- TagAlert® monitor cards
- Choice of vaccination site for toddlers
- Babies born to hepatitis B positive women
- Tetanus-prone wounds: When to give TIG
- Immunisation eligibility extended
-
Packaging changes: Synflorix® & Infanrix®-IPV
- Australian PHAA conference
- Additional DHB funded vaccination programmes
- Pharmac – the new vaccine purchaser
- ImmNuZ survey update
- Egg allergy & MMR – immunise at the practice
- Eligibility – High-risk Pneumococcal Programme
- More on non-funded vaccines
-
Pertussis perspectives - three new videos about pertussis
- Meningococcal A,C,Y,W-135 conjugate vaccine (Menactra®) available in New Zealand
- Pharmacist vaccinators authorised to administer influenza vaccine
- Choosing the correct brand of flu vaccine for children
- Immunisation and pregnancy
- New TagAlert® monitors for National Cold Chain Audit
- Herpes zoster/shingles vaccine (Zostavax®) available in New Zealand
- Immunisation Week 2012
-
Survey What changes would you like for ImmNuZ? - return your survey and be in to WIN one of two $50 vouchers
- A new look IMAC website
- Change to District Immunisation Facilitator service
- Immunisation week 2012
- HPV vaccine eligibility
- Influenza vaccine: Answers to frequently asked questions
- Pneumococcal conjugate vaccine doses
- Change to spacing of Td and Tdap vaccine administration
-
Improving coverage: The next step
2011
- The 7th New Zealand Immunisation Conference and National Immunisation Workshop - Highlights
- Use of paracetamol after immunisation
- Meningococcal vaccines
- Institute of Medicine report - Adverse Effects of Vaccines
- Best practice at the practice - Research update
- Human papillomavirus (HPV) immunisation programme update
- Varicella vaccine - One dose or two?
- Eligibility for funded Tdap (Boostrix®)
- Post-exposure immunisation prophylaxis
- Guidelines for the early delivery of vaccines (prior to the date they are due)
- Guidelines for the use of vaccines/diluents that have expired
- Best practice at the practice - Research update
- Auckland measles outbreak
- New look Immnuz- Tell us what you think!
- Immunisation Schedule changes for 2011
- Pre/post splenectomy immunisation
- Measles in Auckland
- High Risk Pnemococcal Immunisation Programme
- Influenza season 2011
- MMR and Wakefield - The final chapter?
- New vaccine technologies - A report from the 9th Canadian Immunization Conference
- Evidence that Gardsasil® reduces genital wart rates
2010
- 2010 influenza season - One to remember
- 2011 Immunisation Schedule
- Spacing of vaccines
- Breastfeeding and vaccination
- Best practice - Informed decision making
- Active safety surveillance of influenza vaccines
- Private purchase of non-funded vaccines
- Profile of an outreach immunisation service
- Celebrating 60 issues
- IMAC website internationally recognised
- Adult pertussis vaccination
- Latest research - On-time vaccine receipt in the first year does not adversely affect neuropsychological outcomes
- Latest research - Breastfeeding and risk of fever after immunization
- Latest research - Parental vaccine safety concerns in 2009
- Influenza vaccine for children
- New series - Improving coverage
- Authorised non-medical vaccinators can now claim immunisation benefit
- Immunisation coverage - Focus on timeliness
- Tetanus boosters in adults
- Pre/post Splenectomy Immunisation Programme
- Latest research - Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
- Contaminated Rotarix® vaccine
- Latest research - Critical illness due to 2009 A/H1N1 influenza in pregnancy and post partum women: population based cohort study
- New Zealand Hepatitis Foundation
- Influenza immunisation
- Be alert for those only partially immunised against tetanus
- Latest Research - Reduce the use of paracetamol post-immunisation
- National Immunisation Conference 2009 - Highlights
- HPV vaccination and breast cancer
- Sharing best practice - Nine tips to improving immunisation coverage in Mäori populations
- BCG eligibility changes
2009
- Measles
- Safe disposal of sharps
- Correction in Ministry of Health "Childhood Immunisation" booklet
- BCG eligibility
- Latest research - Post-licensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine
- Latest research - Parental refusal of pertussis vaccination is associated with an increased risk of pertussis infection in children
- Miserable measles
- Persistent pertussis
- Latest research - Breastfeeding for pain relief
- Changes to wording on Gardasil® warnings and precautions
- Influenza vaccination for children
- M-M-R® II and Prevenar® - New packaging
- Rotavirus vaccination
- Pertussis on the rise again
- Varicella vaccine can be given with other vaccines
- Gardasil® vaccine schedules
- "Swine flu" and seasonal influenza immunisation
- Talking tetanus with parents
- Latest research - Human papillomavirus (HPV) vaccine can prevent pre-stages of cervical cancer and pre-term birth
- Influenza vaccine 2009
- Latest research - Conjugate pneumococcal vaccine (Prevenar®) having great result
- Latest research - Vaccination of yeast sensitive individuals with Gardasil®
2008
- Communicating with adolescents about human papillomavirus (HPV)
- Vaccination of yeast sensitive individuals with Gardasil®
- Ministry of Health HPV resources
- Hepatitis B serology at 5 months for babies of hepatitis B positive mothers
- Influenza 2009
- Latest research - Vaccine injection technique and reactogenicity-evidence for practice
- Human Papillomavirus (HPV) Immunisation Programme
- Duration of protection after immunisation
- Pertussis immunisation for healthcare personnel
- Dr Paul Offit's New Zealand speaking tour - Highlights
- Latest research - Determining immunisation coverage rates in primary healthcare practices: A simple goal but a complex task
- Human Papillomavirus (HPV) Immunisation Programme
- Cessation of MeNZB™ Immunisation Programme
- Hepatitis Conference 2008 - Highlights
- Latest research - Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: A randomized, multicenter study
- Recommended reading - Parents and nurses during the immunization of children - where is the power? A conversation analysis
- Influenza 2008
- Human papillomavirus (HPV) vaccine concerns addressed
- Latest research - Invasive pneumococcal disease in New Zealand 1998-2005: Capsular serotypes and antimicrobial resistance
2007
- 2008 Immunisation Schedule
- Eligibility for MeNZB™ for children older than five years of age
- Northland Baby Bib focuses on timeliness
- National Immunisation Conference 2007 - Highlights
- Who vaccinates when the regulars are on holiday?
- Latest research - Post marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006
- Latest research - Immunization in the print media: Perspectives presented by the press
- MeNZB™ safety monitoring
- Influenza season 2007
- Latest research - Pain reduction during pediatric immunizations: Evidence-based review and recommendations
- Recommended reading - A prospective study of the effectiveness of the New Zealand meningococcal B vaccine
- Recommended reading - Hospitalisations due to pertussis in New Zealand in the pre-immunisation and mass immunisation eras
- Influenza 2007
- National cold chain audit
- Future vaccines - pneumococcal conjugate, human papillomavirus, measles-mumps-rubella-varicella (MMRV), rotavirus
- Latest research - Prophylaxis with acetaminophen or ibuprofen for prevention of local reactions to the fifth diphtheria-tetanus toxoids-acellular pertussis vaccination: A randomized, controlled trial
- Latest research - Childhood vaccination and nontargeted infectious disease hospitalization
2006
- Chronic fatigue syndrome and immunisation
- Impact of Norwegian TV vaccines programme on confidence in the MeNZB™ vaccine
- The Lakes DHB MeNZB™ Youth Flying Squad (aka The Needle Birds)
- Latest reseach - New Zealand strain meningococcal serogroup B outer membrane vesicle vaccine safety and immunogenicity in healthy infants aged 6-10 weeks
- Cervical cancer control - Human papillomavirus (HPV) vaccines
- Administering multiple injections at one visit
- Influenza season 2006
- MeNZB™ vaccine effectiveness
- Tetanus vaccines - Which vaccine and for whom?
- Latest research - What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study
- Pneumococcal conjugate vaccine
- Thiomersal and autism revisited
- Influenza immunisation popular in 2006
- Latest research - Do recommended high-risk adults benefit from a first influenza vaccination?
- Evolution of the pertussis vaccine schedule - The last 25 years
- Pandemic influenza vaccine
- Seasonal influenza 2006
- Latest research - Optimal technique for intramuscular injection of infants and toddlers: A randomised trial
2005
There are no results for 2005.
Last updated: 06-03-2012
News and Community
Most Popular
Newsletter


